A study in the New England Journal of Medicine (NEJM) has found that women taking antidepressants during the second half of pregnancy run six times the risk of having a child born with a life-threatening lung disorder.
The study, published in the Feb. 9 issue of NEJM, found that the babies suffering from the lung disorder known as persistent pulmonary hypertention cannot get enough oxygen into their bloodstreams because of high pressure in the blood vessels of their lungs, apparently brought on by their mother's use of antidepressants during pregnancy. One in 1,000 newborns typically develops the disorder shortly after birth.
The study has led the U.S. Food and Drug Administration to call for manufacturers of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) -- including Prozac, Paxil, Zoloft and Lexapro --
Read More..
The study, published in the Feb. 9 issue of NEJM, found that the babies suffering from the lung disorder known as persistent pulmonary hypertention cannot get enough oxygen into their bloodstreams because of high pressure in the blood vessels of their lungs, apparently brought on by their mother's use of antidepressants during pregnancy. One in 1,000 newborns typically develops the disorder shortly after birth.
The study has led the U.S. Food and Drug Administration to call for manufacturers of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) -- including Prozac, Paxil, Zoloft and Lexapro --
